Pascal Soriot, Chief Executive Officer

AstraZeneca Annual Report
and Form 20-F Information 2015

2015 was an exceptional year for AstraZeneca as we made significant progress in meeting both our near- and longer-term strategic goals.
Download the Chief Executive Officer’s Review PDF
Watch this year in review

Watch this year in review

At a glance

Life-cycle of a medicine

As a global science-led biopharmaceutical company, our activities span the entire life-cycle of a medicine from Research and Development to Manufacturing and Supply to the global Sales and Marketing of primary care and specialty care medicines that transform lives.

Leif Johansson, Chairman
The Board of Directors has sought to ensure that AstraZeneca’s achievements in 2015 were underpinned by strong corporate governance.
Download the Chairman’s Statement PDF


Additional Shareholder Communications